María D.
Odero
Catedrática de Universidad
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (2)
2019
-
Comment on "pP2A inhibition sensitizes cancer stem cells to ABL tyrosine kinase inhibitors in BCR-ABL human leukemia"
Science Translational Medicine, Vol. 11, Núm. 501
2011
-
Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas
PLoS ONE, Vol. 6, Núm. 10